Circulating Tumor Cell (CTC) Diagnostics Market Report – Research, Industry Analysis Reports and Market Demands

Global Circulating Tumor Cell (CTC) Diagnostics Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

Global Circulating Tumor Cell (CTC) Diagnostics Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

1 Study Coverage

1.1 Circulating Tumor Cell (CTC) Diagnostics Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type
- 1.4.2 CTC Enrichment
- 1.4.3 CTC Detection
1.5 Market by Application
- 1.5.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Application
- 1.5.2 Hospitals and clinics
- 1.5.3 Pharmaceuticals and biotechnology companies
- 1.5.4 Academic research institutes
- 1.5.5 CROs
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Circulating Tumor Cell (CTC) Diagnostics Production
- 2.1.1 Global Circulating Tumor Cell (CTC) Diagnostics Revenue 2014-2025
- 2.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Production 2014-2025
- 2.1.3 Global Circulating Tumor Cell (CTC) Diagnostics Capacity 2014-2025
- 2.1.4 Global Circulating Tumor Cell (CTC) Diagnostics Marketing Pricing and Trends
2.2 Circulating Tumor Cell (CTC) Diagnostics Growth Rate (CAGR) 2019-2025
2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Key Circulating Tumor Cell (CTC) Diagnostics Manufacturers
2.4 Market Drivers, Trends and Issues
2.5 Macroscopic Indicator
- 2.5.1 GDP for Major Regions
- 2.5.2 Price of Raw Materials in Dollars: Evolution

3 Market Size by Manufacturers

3.1 Circulating Tumor Cell (CTC) Diagnostics Production by Manufacturers
- 3.1.1 Circulating Tumor Cell (CTC) Diagnostics Production by Manufacturers
- 3.1.2 Circulating Tumor Cell (CTC) Diagnostics Production Market Share by Manufacturers
3.2 Circulating Tumor Cell (CTC) Diagnostics Revenue by Manufacturers
- 3.2.1 Circulating Tumor Cell (CTC) Diagnostics Revenue by Manufacturers (2014-2019)
- 3.2.2 Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Manufacturers (2014-2019)
3.3 Circulating Tumor Cell (CTC) Diagnostics Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans

4 Circulating Tumor Cell (CTC) Diagnostics Production by Regions

4.1 Global Circulating Tumor Cell (CTC) Diagnostics Production by Regions
- 4.1.1 Global Circulating Tumor Cell (CTC) Diagnostics Production Market Share by Regions
- 4.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Regions
4.2 United States
- 4.2.1 United States Circulating Tumor Cell (CTC) Diagnostics Production
- 4.2.2 United States Circulating Tumor Cell (CTC) Diagnostics Revenue
- 4.2.3 Key Players in United States
- 4.2.4 United States Circulating Tumor Cell (CTC) Diagnostics Import & Export
4.3 Europe
- 4.3.1 Europe Circulating Tumor Cell (CTC) Diagnostics Production
- 4.3.2 Europe Circulating Tumor Cell (CTC) Diagnostics Revenue
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Circulating Tumor Cell (CTC) Diagnostics Import & Export
4.4 China
- 4.4.1 China Circulating Tumor Cell (CTC) Diagnostics Production
- 4.4.2 China Circulating Tumor Cell (CTC) Diagnostics Revenue
- 4.4.3 Key Players in China
- 4.4.4 China Circulating Tumor Cell (CTC) Diagnostics Import & Export
4.5 Japan
- 4.5.1 Japan Circulating Tumor Cell (CTC) Diagnostics Production
- 4.5.2 Japan Circulating Tumor Cell (CTC) Diagnostics Revenue
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Circulating Tumor Cell (CTC) Diagnostics Import & Export
4.6 Other Regions
- 4.6.1 South Korea
- 4.6.2 India
- 4.6.3 Southeast Asia

5 Circulating Tumor Cell (CTC) Diagnostics Consumption by Regions

5.1 Global Circulating Tumor Cell (CTC) Diagnostics Consumption by Regions
- 5.1.1 Global Circulating Tumor Cell (CTC) Diagnostics Consumption by Regions
- 5.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Consumption Market Share by Regions
5.2 North America
- 5.2.1 North America Circulating Tumor Cell (CTC) Diagnostics Consumption by Application
- 5.2.2 North America Circulating Tumor Cell (CTC) Diagnostics Consumption by Countries
- 5.2.3 United States
- 5.2.4 Canada
- 5.2.5 Mexico
5.3 Europe
- 5.3.1 Europe Circulating Tumor Cell (CTC) Diagnostics Consumption by Application
- 5.3.2 Europe Circulating Tumor Cell (CTC) Diagnostics Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 UK
- 5.3.6 Italy
- 5.3.7 Russia
5.4 Asia Pacific
- 5.4.1 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Consumption by Application
- 5.4.2 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Consumption by Countries
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Indonesia
- 5.4.9 Thailand
- 5.4.10 Malaysia
- 5.4.11 Philippines
- 5.4.12 Vietnam
5.5 Central & South America
- 5.5.1 Central & South America Circulating Tumor Cell (CTC) Diagnostics Consumption by Application
- 5.5.2 Central & South America Circulating Tumor Cell (CTC) Diagnostics Consumption by Countries
- 5.5.3 Brazil
5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Consumption by Application
- 5.6.2 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 GCC Countries
- 5.6.5 Egypt
- 5.6.6 South Africa

6 Market Size by Type

6.1 Global Circulating Tumor Cell (CTC) Diagnostics Breakdown Dada by Type
6.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Type
6.3 Circulating Tumor Cell (CTC) Diagnostics Price by Type

7 Market Size by Application

7.1 Overview
7.2 Global Circulating Tumor Cell (CTC) Diagnostics Breakdown Dada by Application
- 7.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Consumption by Application
- 7.2.2 Global Circulating Tumor Cell (CTC) Diagnostics Consumption Market Share by Application (2014-2019)

8 Manufacturers Profiles

9 Production Forecasts

9.1 Circulating Tumor Cell (CTC) Diagnostics Production and Revenue Forecast
- 9.1.1 Global Circulating Tumor Cell (CTC) Diagnostics Production Forecast 2019-2025
- 9.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Forecast 2019-2025
9.2 Circulating Tumor Cell (CTC) Diagnostics Production and Revenue Forecast by Regions
- 9.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Forecast by Regions
- 9.2.2 Global Circulating Tumor Cell (CTC) Diagnostics Production Forecast by Regions
9.3 Circulating Tumor Cell (CTC) Diagnostics Key Producers Forecast
- 9.3.1 United States
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
9.4 Forecast by Type
- 9.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Production Forecast by Type
- 9.4.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Forecast by Type

10 Consumption Forecast

10.1 Consumption Forecast by Application
10.2 Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
- 10.3.1 North America Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast by Countries 2019-2025
- 10.3.2 United States
- 10.3.3 Canada
- 10.3.4 Mexico
10.4 Europe Market Consumption Forecast
- 10.4.1 Europe Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast by Countries 2019-2025
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 UK
- 10.4.5 Italy
- 10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
- 10.5.1 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast by Countries 2019-2025
- 10.5.2 China
- 10.5.3 Japan
- 10.5.4 Korea
- 10.5.5 India
- 10.5.6 Australia
- 10.5.7 Indonesia
- 10.5.8 Thailand
- 10.5.9 Malaysia
- 10.5.10 Philippines
- 10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
- 10.6.1 Central & South America Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast by Country 2019-2025
- 10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
- 10.7.1 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast by Countries 2019-2025
- 10.7.2 Middle East and Africa
- 10.7.3 Turkey
- 10.7.4 GCC Countries
- 10.7.5 Egypt
- 10.7.6 South Africa

11 Upstream, Industry Chain and Downstream Customers Analysis

11.1 Analysis of Circulating Tumor Cell (CTC) Diagnostics Upstream Market
- 11.1.1 Circulating Tumor Cell (CTC) Diagnostics Key Raw Material
- 11.1.2 Typical Suppliers of Key Circulating Tumor Cell (CTC) Diagnostics Raw Material
- 11.1.3 Circulating Tumor Cell (CTC) Diagnostics Raw Material Market Concentration Rate
11.2 Circulating Tumor Cell (CTC) Diagnostics Industry Chain Analysis
11.3 Marketing & Distribution
11.4 Circulating Tumor Cell (CTC) Diagnostics Distributors
11.5 Circulating Tumor Cell (CTC) Diagnostics Customers

12 Opportunities & Challenges, Threat and Affecting Factors

12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter's Five Forces Analysis

13 Key Findings

14 Appendix

14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
14.2 Author Details

Description

Circulating tumor cells (CTCs) are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation.
Global Circulating Tumor Cell (CTC) Diagnostics market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Circulating Tumor Cell (CTC) Diagnostics.

This report researches the worldwide Circulating Tumor Cell (CTC) Diagnostics market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Circulating Tumor Cell (CTC) Diagnostics breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
ApoCell, Inc. (US)
Biocep Ltd. (Israel)
Biocept, Inc. (US)
Biofluidica Microtechnologies LLC (US)
Celltraffix Inc. (US)
Clearbridge Biomedics (Singapore)
Creatv Microtech, Inc. (US)
Cynvenio Biosystems, Inc. (US)
Epic Biosciences Inc. (US)
Fluxion Biosciences, Inc. (US)
Ikonisys, Inc. (US)
IVDiagnostics, Inc. (US)
Janssen Diagnostics LLC (US)
QIAGEN Hannover GmbH (Germany)
RARECELLS SAS (Italy)
ScreenCell (France)
STEMCELL Technologies, Inc. (Canada)

Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Type
CTC Enrichment
CTC Detection
Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Application
Hospitals and clinics
Pharmaceuticals and biotechnology companies
Academic research institutes
CROs

Circulating Tumor Cell (CTC) Diagnostics Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Circulating Tumor Cell (CTC) Diagnostics Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Circulating Tumor Cell (CTC) Diagnostics capacity, production, value, consumption, status and forecast;
To focus on the key Circulating Tumor Cell (CTC) Diagnostics manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Circulating Tumor Cell (CTC) Diagnostics :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.